We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Bill Blonigan Sheppard Mullin Richter & Hampton LLP

Results 1 to 4 of 4



Establishing the weight of evidence after Sciele *

USA - August 13 2012
Patents are presumptively valid under 35 U.S.C. § 282 and can be proven invalid only by clear and convincing evidence.

Co-authors: Eric Gill.


Patents issued in error are presumed valid, but evidence weighs heavily against them *

USA - August 3 2012
Patents are presumptively valid under 35 U.S.C. § 282 and can be proven invalid only by clear and convincing evidence.

Co-authors: Eric Gill.


Supreme Court confirms that generic drug manufacturers can challenge brand-name use-code descriptions in patent litigation *

USA - July 16 2012
Congress designed the Hatch-Waxman Act (codified at 21 U.S.C. § 355(b), (j), (l) and 35 U.S.C. §§ 156, 271, and 282) to inspire medical innovation by giving medical-device and pharmaceutical patent owners a more fruitful patent term while providing follow-on manufacturers to more quickly market their products once medical patents expire.

Co-authors: Nagendra (Nick) Setty .


Courts to play greater role moderating enhanced damages for willful patent infringement *

USA - July 3 2012
In this medical-device patent-infringement action, an Arizona federal jury found that W.L. Gore willfully infringed Bard’s Prosthetic Vascular Graft patent.

Co-authors: Martin Bader.